Zymeworks (NasdaqGS:ZYME) Q1 2026 Earnings call May 07, 2026 04:30 PM ET Company ParticipantsAdam Schayowitz - Head of R&DJohn Miller - Managing Director of Biotech and Pharma Equity ResearchKen Galbraith - Chair and CEOKristin Stafford - CFOPaul Moore - Chief Scientific OfficerReni Benjamin - Managing DirectorSabeen Mekan - SVP and Chief Medical OfficerShrinal Inamdar - VP of Investor RelationsStephen Willey - Managing DirectorYigal Nochomovitz - DirectorConference Call ParticipantsBrian Cheng - AnalystCha ...